NEW YORK (360Dx) – Netscientific said today that its portfolio company ProAxsis has signed a licensing agreement with Queen's University of Belfast for the university's ProteaseTag technology.

The deal gives ProAxsis exclusive intellectual property rights to the technology, which enables the measurement of active protease biomarkers. It is the second licensing agreement ProAxsis has signed with Queens for the technology. The first was established when the company spun out of the university in 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.